title: Uroporphyrinogen decarboxylase: optimizing radiotherapy for head and neck cancer.
authors.forename: Emma
authors.initials: E
authors.lastname: Ito
authors.forename: Kenneth W
authors.initials: KW
authors.lastname: Yip
authors.forename: Fei-Fei
authors.initials: FF
authors.lastname: Liu
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000068818:Cetuximab; D006258:Head and Neck Neoplasms / Q000201:enzymology* / Q000532:radiotherapy*; D006801:Humans; D011166:Porphyrins / Q000627:therapeutic use; D011839:Radiation, Ionizing; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D015996:Survival Rate; D000077704:Tirapazamine; D014227:Triazines / Q000627:therapeutic use; D014575:Uroporphyrinogen Decarboxylase / Q000378:metabolism*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D011166:Porphyrins; D011838:Radiation-Sensitizing Agents; D014227:Triazines; C442892:texaphyrin; D000077704:Tirapazamine; D014575:Uroporphyrinogen Decarboxylase; D000068818:Cetuximab